Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00810329 · ClinicalTrials.gov registry record
Proteomics of Cerebrospinal Fluid in Chronic Fatigue Syndrome
A clinical trial, sponsored by Georgetown University.
- Completed
- Registry status
- 160
- Enrollment target
NCT00810329 is a clinical trial that has completed, run by Georgetown University. The registered enrollment target is 160 participants.
The verdict
NCT00810329 has completed, sponsored by Georgetown University.
- COMPLETED
- Registry status
- 160 participants
- Enrollment target
Study Summary
The purpose of this study is: 1. To identify specific set of proteins in the cerebrospinal fluid (fluid surrounding the brain and the spinal cord), that are believed to be seen in Chronic fatigue syndrome (CFS) patients, but not in healthy controls (HC). A similar study that the investigators had conducted before,suggested that significant changes in proteins in the cerebrospinal fluid may be due to the fundamental pathology of this disorder. 2. Increased cerebrospinal fluid pressure (pressure that helps the cerebrospinal fluid to move around the brain and the spinal cord), may be related with certain symptoms like headache, sleep problems, light headedness, increased pain, excessive tiredness (fatigue) even with minimal work and memory problems. 3. Assessment of Autonomic Nervous system function (Sympathetic nervous system)between the CFS and HC. 4. Perform Lung Function Testing or pulmonary function test to estimate the lung capacities and score shortness of breath while performing breathing maneuvers. 5. Dolorimetry (18 tender point test) for assessment of pain threshold. 6. Capsaicin skin test 7. Allergy skin test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2007-07 |
| Est. Completion | 2011-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00810329
The ClinicalTrials.gov registry entry for NCT00810329 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 160 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Georgetown University, which has 227 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00810329 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00810329 about?
NCT00810329 is a clinical study titled "Proteomics of Cerebrospinal Fluid in Chronic Fatigue Syndrome". The purpose of this study is: 1. To identify specific set of proteins in the cerebrospinal fluid (fluid surrounding the brain and the spinal cord), that are believed to be seen in Chronic fatigue syndrome (CFS) patients, but not in healthy controls (HC). A similar study that the investigators had c...
What is the current status of trial NCT00810329?
This trial is currently completed. The enrollment target is 160 participants. The study started on 2007-07. Estimated completion is 2011-04.
Who is sponsoring clinical trial NCT00810329?
This trial is sponsored by Georgetown University, which has 227 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.